NYSE:MRK • US58933Y1055
We assign a fundamental rating of 6 out of 10 to MRK. MRK was compared to 191 industry peers in the Pharmaceuticals industry. While MRK has a great profitability rating, there are some minor concerns on its financial health. MRK has a decent growth rate and is not valued too expensively. Finally MRK also has an excellent dividend rating. These ratings could make MRK a good candidate for dividend investing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.69% | ||
| ROE | 36.71% | ||
| ROIC | 20.32% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 36.99% | ||
| PM (TTM) | 29.63% | ||
| GM | 77.69% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.17 | ||
| Altman-Z | 4.34 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.66 | ||
| Quick Ratio | 1.44 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.99 | ||
| Fwd PE | 22.04 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.68 | ||
| EV/EBITDA | 11.27 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.9% |
119.24
-0.07 (-0.06%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.9% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.99 | ||
| Fwd PE | 22.04 | ||
| P/S | 4.61 | ||
| P/FCF | 22.68 | ||
| P/OCF | 17.34 | ||
| P/B | 5.71 | ||
| P/tB | 19.8 | ||
| EV/EBITDA | 11.27 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.69% | ||
| ROE | 36.71% | ||
| ROCE | 23.54% | ||
| ROIC | 20.32% | ||
| ROICexc | 24.8% | ||
| ROICexgc | 44.78% | ||
| OM | 36.99% | ||
| PM (TTM) | 29.63% | ||
| GM | 77.69% | ||
| FCFM | 20.31% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.17 | ||
| Debt/EBITDA | 1.41 | ||
| Cap/Depr | 87.9% | ||
| Cap/Sales | 6.25% | ||
| Interest Coverage | 17.91 | ||
| Cash Conversion | 60.24% | ||
| Profit Quality | 68.56% | ||
| Current Ratio | 1.66 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 4.34 |
ChartMill assigns a fundamental rating of 6 / 10 to MRK.
ChartMill assigns a valuation rating of 6 / 10 to MERCK & CO. INC. (MRK). This can be considered as Fairly Valued.
MERCK & CO. INC. (MRK) has a profitability rating of 8 / 10.
The financial health rating of MERCK & CO. INC. (MRK) is 5 / 10.
The dividend rating of MERCK & CO. INC. (MRK) is 7 / 10 and the dividend payout ratio is 42.6%.